According to a new study done by GlaxoSmithKline the future of a Vaccine against Cancer might be possible. Their current study shows that when given their Cervarix vaccine girls aged 10 to 14 who received GlaxoSmithKline’s vaccine to prevent infection with the virus that causes cervical cancer had immune responses twice as strong as women 15-25 years old given the vaccine. To view the complete report please click here.
Sorry, the comment form is closed at this time.